ISPOR 22nd Annual International Meeting to Focus on Social and Policy Change in Health Care

Published May 9, 2017
Conference to Be Held May 20-24, 2017 in Boston Princeton, NJ—May 9, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading educational and scientific organization for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions for its upcoming 22nd Annual International Meeting in Boston, MA, USA. The theme of the conference, Evidence and Value in a Time of Social and Policy Change, will feature key discussions of the issues impacting health care today. The International Meeting is expected to draw more than 4,000 health care stakeholders including policy makers, payers, thought leaders, researchers, academicians, decision makers, and patient representatives. Key sessions include: Plenary #1: Where Is US Health Policy Going? (Monday, May 22, 2017) This session features 4 leading health economists (2 who have advised Democrats and 2 who have counseled Republicans) to discuss key topical health policy issues facing the United States and the world. Plenary speakers include:
  • Moderator: Peter J. Neumann, ScD, Professor and Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
  • Speaker: Joseph R. Antos, PhD, Wilson H. Taylor Scholar in Health Care and Retirement Policy, American Enterprise Institute, Washington, DC, USA
  • Speaker: David M. Cutler, PhD, Professor, Otto Eckstein Professor of Applied Economics, Harvard University, Cambridge, MA, USA
  • Speaker: Jonathan Gruber, PhD, Ford Professor of Economics, Massachusetts Institute of Technology, Cambridge, MA, USA
  • Speaker: Gail R. Wilensky, PhD, Economist and Senior Fellow, Project HOPE, Baltimore, MD, USA
Plenary #2: Social Network Interventions and Population Health (Tuesday, May 23, 2017) This session features the work of Dr. Nicholas Christakis who will review recent research from his lab describing two classes of social network interventions—involving both offline and online networks—that can help make the world better. He will also discuss how by understanding social influence, it is possible to intervene in social systems to make improvements in diverse arenas such as health, wealth, cooperation, coordination, and learning. Speakers include: Plenary #3: When Do We Really Need Randomized Controlled Trials? (Wednesday, May 24, 2017) This session will address how big data is changing the strength of evidence in observational studies and how this is influencing the types of studies where randomization is necessary. Speakers include:
  • Moderator: William H. Crown, PhD, Chief Scientific Officer, OptumLabs, Boston, MA, USA
  • Speaker: Robert M. Califf, MD, Donald F. Fortin, MD Professor of Cardiology, School of Medicine, Duke University, Durham, NC, USA
  • Speaker: Steven Goodman, MD, MHS, PhD, Associate Dean of Clinical and Translational Research and Professor of Medicine and Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA
  • Speaker: Sebastian Schneeweiss, MD, ScD, Professor of Medicine, Harvard Medical School and Vice Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
In addition to the topical plenary sessions, ISPOR’s Annual International Meeting will feature 24 issues panels, 24 workshops, 12 forums, 9 educational symposia, and a variety podium and poster presentations. Breakout sessions will focus on a variety of compelling topics, including real-world evidence, value assessment frameworks, the patient voice, health care affordability, 21st Century Cures, and drug pricing. On the days immediately preceding the conference, ISPOR will offer its renowned Essential HEOR Education curriculum of half- and full-day short courses on May 20-21, 2017. The ISPOR Short Course Program offers 30+ HEOR courses across 7 tracks. Additional information on the conference can be found at: Conference Information | Registration | Short Course Program |Sponsorship | Exhibits | Press

###

ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×